Claim Missing Document
Check
Articles

Found 2 Documents
Search

Total Intravenous Anesthesia for Coronary Artery Bypass Grafting: A Case Report of Successful Hemodynamic Management and Early Recovery Sriwahyuniati Purwaningsih; Anas Alatas; Yudi Hadinata
Eduvest - Journal of Universal Studies Vol. 6 No. 7 (2026): Eduvest - Journal of Universal Studies
Publisher : Green Publisher Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59188/eduvest.v6i7.53332

Abstract

Coronary artery bypass grafting (CABG) is a complex cardiac surgical procedure that requires precise anesthetic management to maintain hemodynamic stability and support optimal postoperative recovery. Total intravenous anesthesia (TIVA) has emerged as an alternative anesthetic technique in cardiac surgery due to its advantages in anesthetic titration, hemodynamic control, and facilitation of fast-track recovery protocols. This case report aimed to describe the application of TIVA in a high-risk CABG patient and evaluate its effectiveness in achieving intraoperative stability and early postoperative recovery. A case report was conducted involving a 66-year-old male patient with three-vessel coronary artery disease who underwent CABG at the National Cardiovascular Center Harapan Kita, Jakarta. Clinical data were collected from preoperative assessments, intraoperative anesthesia records, hemodynamic monitoring parameters, and postoperative intensive care management in accordance with the CARE guidelines. The patient received TIVA using propofol, sufentanil, and rocuronium, supported by multimodal monitoring, including the Bispectral Index (BIS), Near-Infrared Spectroscopy (NIRS), arterial line monitoring, and central venous catheter monitoring. The results demonstrated stable intraoperative hemodynamic conditions with appropriate vasoactive support using dobutamine and nitroglycerin. The patient successfully underwent early extubation eight hours after surgery, with acceptable postoperative laboratory parameters and no significant anesthetic complications. In conclusion, TIVA combined with comprehensive hemodynamic monitoring and fast-track protocols provided effective anesthetic management for CABG, supporting cardiovascular stability and early recovery. Further studies involving larger patient populations are required to confirm its broader clinical benefits.
Establishing a TAVR Program in a Non-ECMO Center: Anesthetic Considerations and Safety Workflow Defitra Nanda Sasmita; Anas Alatas
Jurnal Locus Penelitian dan Pengabdian Vol. 5 No. 7 (2026): JURNAL LOCUS: Penelitian dan Pengabdian
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/locus.v5i7.6130

Abstract

Optimal anesthetic management during the initiation of a transcatheter aortic valve replacement (TAVR) program in centers without extracorporeal membrane oxygenation (ECMO) capability remains underexplored. This case report describes anesthetic considerations and contingency planning for establishing a new TAVR program in a cardiac catheterization laboratory. A 66-year-old male patient with severe aortic stenosis (valve area: 0.74 cm²; mean gradient: 43.89 mmHg; ejection fraction: 47%), coronary artery disease, congestive heart failure (NYHA class II), and chronic kidney disease stage III underwent transfemoral TAVR under general anesthesia as the inaugural procedure of the program. The procedure was performed in a cardiac catheterization laboratory without on-site ECMO support, with cardiac surgery standby and cardiopulmonary bypass equipment prepared in an adjacent operating room. Hemodynamic management during rapid ventricular pacing (180 beats/min for 10 seconds during balloon valvuloplasty and 120 beats/min during valve deployment) included preemptive phenylephrine boluses (total dose: 2 mg) and cautious crystalloid administration (500 mL). A 27 mm VitaFlow valve was successfully deployed. Post-deployment transesophageal echocardiography demonstrated mild paravalvular leak without intravalvular regurgitation or valve dislodgement. The patient was discharged on postoperative day 3 without complications. General anesthesia supported by structured hemodynamic management protocols and clearly defined cardiac surgery contingency planning enabled safe TAVR implementation during program initiation in a non-ECMO center. This case provides a practical framework for institutions establishing similar programs without immediate ECMO capability.